News

Gene TherapiesR&D project spotlight: Towards continuous manufacturing for high-dose, cost-efficient rAAV therapies
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2025202420232022 →
Regulatory Round-up - July 2024Regulatory Round-up - July 2024Challenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cellsChallenge Theme R&D spotlight: Identifying potential targets to monitor and control differentiation of stem cells to haematopoietic progenitor cellsCGT Catapult establishes consortium to improve AAV formulationCGT Catapult establishes consortium to improve AAV formulationRegulatory Round-up - June 2024Regulatory Round-up - June 2024Plurify and the Cell and Gene Therapy Catapult to develop technology that improves purity of cell therapiesPlurify and the Cell and Gene Therapy Catapult to develop technology that improves purity of cell therapiesRegulatory Round-up - May 2024Regulatory Round-up - May 2024CATTI and the Cell and Gene Therapy Catapult to establish shared training standards for advanced therapies manufacturingCATTI and the Cell and Gene Therapy Catapult to establish shared training standards for advanced therapies manufacturingCGT Catapult establishing digital and automation testbeds to enable the scale-up of advanced therapy manufacturingCGT Catapult establishing digital and automation testbeds to enable the scale-up of advanced therapy manufacturingChallenge Theme R&D spotlight: Development of an end-to-end scalable AAV platformChallenge Theme R&D spotlight: Development of an end-to-end scalable AAV platformUK and Swiss consortium to apply innovative technologies to lower cost of manufacturing cell and gene therapiesUK and Swiss consortium to apply innovative technologies to lower cost of manufacturing cell and gene therapiesTouchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapiesTouchlight, Cell and Gene Therapy Catapult and Complement Therapeutics to develop innovative manufacturing process for gene therapiesRegulatory Round-up - April 2024Regulatory Round-up - April 2024